| Term 
 
        | atropine (AKA hyoscyamine and analogs) |  | Definition 
 
        | ACh/Muscarinic Antagonists racemic mixture of d, l-hyoscyamine. The l isomer is pharmacologically more active.
 Homotropine is a semisynthetic analog of atropine
 |  | 
        |  | 
        
        | Term 
 
        | scopolamine (AKA hyoscine and analogs) |  | Definition 
 
        | ACh/Muscarinic Antagonists Methscopolamine is a quaternary analog that does not cross the blood-brain barrier
 pharmacologic effects and uses of scopolamine are generally similar to those of atropine except it has more of a CNS depressant effect (sedation and amnesia) than atropine
 prevention of motion-sickness and vertigo
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists nonquaternary antimuscarinic agent
 intestinal antispasmodic for the treatment of irritable bowel syndrome
 |  | 
        |  | 
        
        | Term 
 
        | propantheline (Pro-Banthine) |  | Definition 
 
        | ACh/Muscarinic Antagonists antispasmodic effects (eg in the treatment of irritable bowel syndrome)
 quaternary compound with few CNS effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists quaternary antimuscarinic agent (no CNS effects)
 in anesthesiology as a preop medication to dry respiratory secretions and inhibit vagal reflexes
 general purpose antimuscarinic agent
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists quaternary salt administered by inhalation for the treatment of asthma and COPD
 few systemic effects
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists quaternary salt administered by inhalation for the treatment of asthma and COPD
 few systemic effects
 Longer duration of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists centrally acting antimuscarinics used in the treatment of Parkinson's disease or drug-induced Parkinsonism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists centrally acting antimuscarinics used in the treatment of Parkinson's disease or drug-induced Parkinsonism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists urinary incontinence due to over active bladder.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists urinary incontinence due to over active bladder.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists used to dilate the pupil for opthamologic examination
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ACh/Muscarinic Antagonists urinary incontinence due to over active bladder.
 |  | 
        |  |